• AJMCAJMC
  • Center for Biosimilars
The Center for Biosimilars - Biosimilars, Health Economics & Insights
The Center for Biosimilars - Biosimilars, Health Economics & Insights
Business Practice
View MoreBusinessDevelopmentLegalPolicyPracticeRegulatory
News
All News
Product Approvals and Launches
Media
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Stakeholder Summit
Compendia
Bone Health
Dermatology
Diabetes
Gastroenterology
Hematology
Immunology
Neurology
Oncology
Ophthalmology
Rare Disease
Respiratory
Rheumatology
Conferences
Conference Coverage
Conference Listing
CME/CE
Resources
Authors
Biosimilar Resources
Interactive Tools
Partners
Polls and Quizzes
Sponsored
WHEN CHOICE ARRIVES: Competition & Consequences
SubscribeBIOSIMILAR APPROVALS
  • About
  • Editorial
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

© 2025 MJH Life Sciences and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.

Advertisement
Business PracticeSee All >
  • Business
  • Development
  • Legal
  • Policy
  • Practice
  • Regulatory
  • About
  • Editorial
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy
  • MJHLS Brand Logo

© 2025 MJH Life Sciences™ and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.

Regulation, Policy, and Litigation in Biosimilars

EP. 1: State Laws and Biosimilar Substitution

October 30th 2017

EP. 2: The PTAB's Role in Biosimilar Patent Disputes

October 30th 2017

EP. 3: The Need for Clarity After Sandoz v Amgen

October 30th 2017

EP. 4: Upcoming Patent Litigation in Biosimilars

October 30th 2017

EP. 5: Challenges Ahead for Biosimilars

October 30th 2017

Advertisement
Advertisement